The private equity exit environment of 2022–2025 has been profoundly disrupted: elevated interest rates compressed IPO valuations, strategic buyers faced tighter financing and higher hurdle rates, and the secondary buyout market — where PE sponsors sell to other PE sponsors — experienced multiple compression as LBO return assumptions adjusted to the new rate environment. In this context, two liquidity management instruments have moved from niche to mainstream in the PE toolkit: NAV financing (Net Asset Value-based credit facilities secured against a fund's portfolio of investments) and continuation vehicles (GP-led secondary transactions that transfer selected portfolio companies into a new vehicle, providing liquidity to existing LPs while allowing the GP to retain control of assets with further value creation potential). Both instruments raise significant questions of governance, LP alignment and regulatory treatment under AIFMD II — making expert structuring advice essential.

NAV Financing: Structure, Security and Leverage Mechanics

A NAV facility is a credit line extended to a private equity fund (or fund-of-funds) secured against the net asset value of the fund's portfolio investments. Unlike subscription line financing (secured against LP capital commitments), NAV facilities are secured against the actual portfolio — typically through a pledge of fund interests, assignment of distributions from portfolio companies, or direct pledge of GP's interest in the fund. NAV facilities are typically structured as revolving credit facilities or term loans with a leverage ratio of 10–25% of portfolio NAV, reflecting the illiquid and diverse nature of the collateral.

The economic rationale for NAV financing: a fund approaching the end of its term (typically year 8–12 of a 10-year fund life) may hold portfolio companies with significant residual value potential but insufficient time in the existing fund structure to realise that value through an optimal exit. NAV financing provides liquidity that can be used for: distributions to LPs (enabling the GP to return capital without forced exit at depressed valuations); add-on acquisitions within existing portfolio companies (enabling buy-and-build strategies without additional LP capital calls); or bridge financing for portfolio companies facing short-term liquidity needs.

NAV facility lenders — predominantly private credit funds, specialised NAV lending platforms (17Capital, Ares, Pemberton) and some bank lenders — price facilities based on the quality and diversification of the underlying portfolio, the LP base quality, and the fund's track record. Typical terms: SOFR/EURIBOR + 300–500 bps, LTV covenants at 15–20% of NAV, with equity cure provisions allowing GPs to inject additional portfolio value through new investments. Covenant packages are lighter than traditional corporate lending, reflecting the portfolio diversification as a risk mitigant.

Continuation Vehicles: Structure and LP Alignment

A continuation vehicle (CV) — also called a GP-led secondary — is a transaction in which a GP transfers one or more portfolio companies from a maturing fund into a newly formed vehicle (the continuation fund), with a new investment period and a new waterfall. Existing LPs in the original fund are offered a choice: they can either (i) roll their interests into the continuation vehicle (maintaining exposure to the transferred assets) or (ii) elect to receive a cash exit at the transaction price established through the CV process. Cash liquidity is typically provided by a secondary market investor (a GP-led secondary buyer) who acquires the interests of exiting LPs at the CV transaction price.

The economics of a CV from the GP's perspective: the GP retains control of high-conviction portfolio companies that it believes have significant remaining value creation potential — without being forced to exit at a point in the market cycle where valuations are depressed or strategic buyers are absent. The GP typically negotiates a new economics arrangement for the continuation vehicle (new management fee, new carried interest waterfall with a hurdle rate) — creating a potential conflict of interest between the GP's incentive to retain assets in a CV (capturing future carry) and the exiting LPs' interest in maximising the CV exit price.

Governance and LP Protection in CV Transactions

The conflict of interest inherent in GP-led secondary transactions — the GP simultaneously acts as seller (on behalf of the original fund's LPs) and as buyer (on behalf of the continuation vehicle) — has attracted regulatory attention and LP governance reform. Market best practice, codified in the ILPA GP-Led Secondaries Guidelines (2023 update), requires: an independent fairness opinion from an independent valuation firm (not the GP's existing portfolio valuation advisor); formation of an independent LP Advisory Committee (LPAC) with authority to approve or reject the CV terms; a genuine liquidity option (the cash exit must be credible — priced at or near fair value, not at a significant discount designed to coerce LP rollover); and full disclosure of the GP's fee economics in the continuation vehicle.

Under AIFMD II (Directive (EU) 2024/927), additional requirements apply to EU-registered AIFMs conducting GP-led secondary transactions: enhanced conflict of interest disclosure under Article 14 AIFMD, notification requirements to national competent authorities for material changes in investment strategy, and updated investor disclosure documentation (Annex IV reporting). For non-EU GPs marketing continuation vehicles to EU institutional investors under the AIFMD National Private Placement Regime (NPPR), compliance with applicable NPPR conditions in each target jurisdiction must be confirmed before marketing commences.

Valuation in NAV Facilities and Continuation Vehicles

Valuation is the technical foundation of both NAV facilities and continuation vehicles — and the source of the most significant execution risk in each instrument. For NAV facilities, portfolio valuation determines the borrowing base; lenders typically apply haircuts of 20–40% to the GP's NAV figures, and independent third-party valuation reviews are standard for facilities above €100 million. For continuation vehicles, the CV transaction price sets the cash exit consideration for rolling LPs and determines the GP's carry crystallisation — making independent valuation critical for LPAC approval and LP confidence in the process.

Common valuation methodologies in PE portfolio contexts: comparable company multiples (EV/EBITDA, EV/Revenue for growth companies), DCF with portfolio-specific discount rates, and recent transaction evidence from comparable M&A. For early-stage or loss-making portfolio companies, revenue multiples and milestone-based probability-weighted scenarios are more commonly applied. Valuation disputes in CV transactions — where exiting LPs believe the CV price undervalues the portfolio company — can delay or derail the transaction and damage the GP's reputation with the LP community.

Secondary Market Dynamics: Pricing and Liquidity

The secondary market for PE interests — both LP-led secondaries (LPs selling fund interests) and GP-led secondaries (continuation vehicles) — has grown from approximately USD 50 billion in annual volume (2019) to over USD 130 billion globally (2024), according to Greenhill Cogent and Lazard secondary market data. This growth reflects both the supply of liquidity-seeking sellers (LPs facing overallocation, denominator effect adjustments, or portfolio rebalancing) and the institutionalisation of secondary buyers (Blackstone Strategic Partners, Ardian, Lexington Partners, Coller Capital, HarbourVest).

Pricing dynamics in the GP-led secondary market (2024): single-asset continuation vehicles involving high-quality, performing assets trade at 90–100% of NAV or above (at premium where the GP can demonstrate strong remaining value creation path). Multi-asset continuation vehicles command lower prices due to portfolio selection adverse selection concerns. LP-led sales of broad fund interests trade at 80–95% of NAV depending on fund vintage, sector and performance trajectory. The narrowing of secondary market discounts from the 2022–2023 levels (when some LP-led secondaries traded at 70–80% of NAV) reflects improved clarity on interest rate trajectory and a recovery in PE asset valuations.

Regulatory Outlook: AIFMD II, ELTIF 2.0 and Transparency Requirements

The regulatory environment for NAV financing and continuation vehicles is evolving rapidly. AIFMD II (transposition deadline: April 2026) introduces enhanced requirements for loan-originating AIFs and leverage reporting — with NAV facilities treated as fund-level borrowing under AIFMD leverage calculation methodologies, requiring disclosure in the fund's Annex IV regulatory reporting. The ELTIF 2.0 framework (Regulation (EU) 2023/606, applicable from January 2024) enables retail investor access to private equity structures including continuation vehicles — with specific asset diversification, liquidity management and redemption mechanism requirements that must be addressed in ELTIF-eligible continuation vehicle structures. For GPs seeking to access retail capital pools through continuation vehicles, ELTIF 2.0 compliance adds regulatory complexity but opens a materially larger investor universe than institutional-only alternatives.